{"id":"W4415519843","doi":"10.1016/j.jtho.2025.09.033","title":"OA02.03 Overall Survival (OS) with Neoadjuvant Nivolumab Plus Chemotherapy by Surgical Outcomes in the Phase 3 CheckMate 816 Study","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Trinity College","funders":"","keywords":"Nivolumab; Overall survival; Chemotherapy; Phases of clinical research; Neoadjuvant therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00141302,0.0004648593,0.0008058336,0.0001721915,0.000296227,0.001322063,0.000453935,0.0005135953,0.002768945],"category_scores_gemma":[0.001465434,0.000236288,0.002398825,0.0003748469,0.000306815,0.0006758419,0.0004286916,0.001179139,0.0003972288],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004768208,"about_ca_system_score_gemma":0.0007021279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001224377,"about_ca_topic_score_gemma":0.003337421,"domain_scores_codex":[0.9995292,0.0001882829,0.00003133156,0.0001097391,0.00004669911,0.00009465246],"domain_scores_gemma":[0.9989543,0.0002823696,0.000320473,0.0001223475,0.00007792292,0.0002426094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4963836,0.002313157,0.4015506,0.001286406,0.01534798,0.0002141182,0.0001987207,0.001891085,0.009415112,0.0006417425,0.00757067,0.06318685],"study_design_scores_gemma":[0.06147548,0.04846536,0.8587762,0.0002691876,0.01598269,0.0003123626,0.0001996409,0.001610106,0.001818259,0.0009847123,0.01002109,0.00008495581],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909373,0.003767466,0.0001858395,0.0002811482,0.0001223944,0.0001031719,0.002354298,0.00001622948,0.002232146],"genre_scores_gemma":[0.9941229,0.0007591433,0.0001945958,0.0004408808,0.0001040537,0.0001525068,0.002947617,0.00001656483,0.00126159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002768945,"threshold_uncertainty_score":0.009262979,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02132153728576376,"score_gpt":0.4310157800900384,"score_spread":0.4096942428042747,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}